Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.

Míreanna comhchosúla

• COMMIT/CCS-2 Clopidogrel and Metoprolol in Myocardial Infarction Trial/Second Chinese Cardiac Study
  de réir: Collins, R
  Foilsithe / Cruthaithe: (2005)
• COMMIT/CCS-2 (Clopidogrel and Metoprolol in Myocardial Infarction Trial/Second Chinese Cardiac Study)
  de réir: Chen, Z
  Foilsithe / Cruthaithe: (2005)
• Gender difference in prognosis after acute MI among 45,852 Chinese patients in COMMIT/CCS2
  de réir: Chen, Y, et al.
  Foilsithe / Cruthaithe: (2009)
• ORAL CAPTOPRIL VERSUS PLACEBO AMONG 13634 PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION - INTERIM-REPORT FROM THE CHINESE CARDIAC STUDY (CCS-1)
  de réir: Liu, L, et al.
  Foilsithe / Cruthaithe: (1995)
• Social Acceptance of CCS
  de réir: Atsuko TANAKA
  Foilsithe / Cruthaithe: (2020-11-01)